Peripheral BDNF: A candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia

Psychological Medicine

Volumn 45, Issue 4, 2015, Pages 841-854

  Skilleter, A J ^a,b,c   Weickert, C S ^a,b,c   Vercammen, A ^a,b,c,d   Lenroot, R ^a,b,c   Weickert, T W ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

BDNF; biomarker; brain derived neurotrophic factor; functional MRI; plasma; probabilistic association learning; schizophrenia

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; BLOOD; BRAIN CORTEX; FEMALE; HUMAN; LEARNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ASSOCIATION LEARNING; BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROBABILITY LEARNING; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84927654492     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714001925     Document Type: Article

References (90)

1. Alexander GE, De Long MR, Strick PL (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9, 357-381.
2. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997). Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860.
3. Altar CA, Di Stefano PS (1998). Neurotrophin trafficking by anterograde transport. Trends in Neurosciences 21, 433-437.
4. Berman KF, Zec RF, Weinberger DR (1986). Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Archives of General Psychiatry 43, 126-135.
5. Braun A, Lommatzsch M, Mannsfeldt A, Neuhaus-Steinmetz U, Fischer A, Schnoy N, Lewin GR, Renz H (1999). Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. American Journal of Respiratory Cell and Molecular Biology 21, 537-546.
6. Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S (2007). Brain derived neurotropic factor in first-episode psychosis. Schizophrenia Research 91, 1-5.
7. Chlan-Fourney J, Ashe P, Nylen K, Juorio AV, Li XM (2002). Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Research 954, 11-20.
8. Dempster E, Toulopoulou T, McDonald C, Bramon E, Walshe M, Filbey F, Wickham H, Sham PC, Murray RM, Collier DA (2005). Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134B, 73-75.
9. Dieni S, Matsumoto T, Dekkers M, Rauskolb S, Ionescu MS, Deogracias R, Gundelfinger ED, Kojima M, Nestel S, Frotscher M, Barde YA (2012). BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. Journal of Cell Biology 196, 775-788.
10. Dugich-Djordjevic MM, Tocco G, Lapchak PA, Pasinetti GM, Najm I, Baudry M, Hefti F (1992). Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience 47, 303-315.
11. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
12. Ernfors P, Lee KF, Jaenisch R (1994). Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147-150.
13. Fabri M, Burton H (1991). Ipsilateral cortical connections of primary somatic sensory cortex in rats. Journal of Comparative Neurology 311, 405-424.
14. Fera F, Weickert TW, Goldberg TE, Tessitore A, Hariri A, Das S, Lee S, Zoltick B, Meeter M, Myers CE, Gluck MA, Weinberger DR, Mattay VS (2005). Neural mechanisms underlying probabilistic category learning in normal aging. Journal of Neuroscience 25, 11340-11348.
15. First MB, Spitzer RL, Gibbon M, Williams JB (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I/P). Biometric Research Department, New York State Psychiatric Institute: New York, NY.
16. Foerde K, Poldrack RA, Khan BJ, Sabb FW, Bookheimer SY, Bilder RM, Guthrie D, Granholm E, Nuechterlein KH, Marder SR, Asarnow RF (2008). Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning. Neuropsychology 22, 100-109.
17. Gall C, Lauterborn J, Bundman M, Murray K, Isackson P (1991). Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Research 4, 225-245.
18. Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F (2007). Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neuroscience Letters 420, 45-48.
19. Goodman LJ, Valverde J, Lim F, Geschwind MD, Federoff HJ, Geller AI, Hefti F (1996). Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Molecular and Cellular Neurosciences 7, 222-238.
20. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ (2011). Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 16, 960-972.
21. Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR (2007). Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. Journal of Psychiatric Research 41, 31-35.
22. Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, Juvancic-Heltzel J, Murray L (2008). Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. Journal of Geriatric Psychiatry and Neurology 21, 166-170.
23. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 23, 6690-6694.
24. Hartmann M, Heumann R, Lessmann V (2001). Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO Journal 20, 5887-5897.
25. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA (2005). Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. Journal of Neuroscience 25, 372-383.
26. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO Journal 9, 2459-2464.
27. Horan WP, Green MF, Knowlton BJ, Wynn JK, Mintz J, Nuechterlein KH (2008). Impaired implicit learning in schizophrenia. Neuropsychology 22, 606-617.
28. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 13-20.
29. Hsieh JH, Lin WM, Chiang H, Chang LY, Wu CT, Pu CM, Wu JT, Hsieh ST (2013). Patterns of target tissue reinnervation and trophic factor expression after nerve grafting. Plastic and Reconstructive Surgery 131, 989-1000.
30. Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC (2003). Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 801-807.
31. Karege F, Schwald M, Cisse M (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters 328, 261-264.
32. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
33. Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A (2008). Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 33, 3111-3125.
34. Kim HW, Cheon Y, Modi HR, Rapoport SI, Rao JS (2012). Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain. Psychopharmacology 222, 663-674.
35. Komulainen P, Pedersen M, Hanninen T, Bruunsgaard H, Lakka TA, Kivipelto M, Hassinen M, Rauramaa TH, Pedersen BK, Rauramaa R (2008). BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiology of Learning and Memory 90, 596-603.
36. Koralek KA, Olavarria J, Killackey HP (1990). Areal and laminar organization of corticocortical projections in the rat somatosensory cortex. Journal of Comparative Neurology 299, 133-150.
37. Lee BH, Kim YK (2009). Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology 59, 51-58.
38. Le Master AM, Krimm RF, Davis BM, Noel T, Forbes ME, Johnson JE, Albers KM (1999). Overexpression of brain-derived neurotrophic factor enhances sensory innervation and selectively increases neuron number. Journal of Neuroscience 19, 5919-5931.
39. Leucht S, Wahlbeck K, Hamann J, Kissling W (2003). New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361, 1581-1589.
40. Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR (2001). BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. European Journal of Neuroscience 14, 135-144.
41. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC (2005). The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology of Aging 26, 115-123.
42. Lu B (2003). BDNF and activity-dependent synaptic modulation. Learning and Memory 10, 86-98.
43. Lu B, Chow A (1999). Neurotrophins and hippocampal synaptic transmission and plasticity. Journal of Neuroscience Research 58, 76-87.
44. Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE (2013). Glutamate in schizophrenia: a focused review and meta-analysis of (1) H-MRS studies. Schizophrenia Bulletin 39, 120-129.
45. Martocchia A, Curto M, Scaccianoce S, Comite F, Xenos D, Nasca C, Falaschi GM, Ferracuti S, Girardi P, Nicoletti F, Falaschi P (2014). Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report. Aging Clinical and Experimental Research 26, 461-464.
46. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002). Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neuroscience 5, 267-271.
47. Mitic M, Lukic I, Bozovic N, Djordjevic J, Adzic M (2014). Fluoxetine signature on hippocampal MAPK signalling in sex-dependent manner. Journal of Molecular Neuroscience. Published online: 21 May 2014. doi:10.1007/S12031-014-0328-1.
48. Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, Kulkarni J, Curtis J, O'Donnell M, Weickert CS, Weickert TW (2012). Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia. Molecular Psychiatry 17, 280-289.
49. Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, Bullmore ET, Robbins TW, Fletcher PC (2008). Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry 13, 239, 267-276.
50. Paelecke-Habermann Y, Paelecke M, Giegerich K, Reschke K, Kubler A (2013). Implicit and explicit reward learning in chronic nicotine use. Drug and Alcohol Dependence 129, 8-17.
51. Palmer BW, Dawes SE, Heaton RK (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychology Review 19, 365-384.
52. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37, 1553-1561.
53. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW (1997). Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120 (Pt 10), 1823-1843.
54. Pedrini M, Chendo I, Grande I, Lobato MI, Belmonte-de-Abreu PS, Lersch C, Walz J, Kauer-Sant'anna M, Kapczinski F, Gama CS (2011). Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neuroscience Letters 491, 207-210.
55. Pirildar S, Gonul AS, Taneli F, Akdeniz F (2004). Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28, 709-713.
56. Poldrack RA, Prabhakaran V, Seger CA, Gabrieli JD (1999). Striatal activation during acquisition of a cognitive skill. Neuropsychology 13, 564-574.
57. Poo MM (2001). Neurotrophins as synaptic modulators. Nature Reviews Neuroscience 2, 24-32.
58. Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S, Erne B, Sendtner M, Schaeren-Wiemers N, Korte M, Barde YA (2010). Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. Journal of Neuroscience 30, 1739-1749.
59. Ray MT, Shannon Weickert C, Webster MJ (2014). Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Translational Psychiatry 4, e389.
60. Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL (2008). Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neuroscience Letters 439, 157-159.
61. Rizos EN, Papadopoulou A, Laskos E, Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K, Lykouras L (2010). Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World Journal of Biological Psychiatry 11, 251-255.
62. Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, Gournellis R, Lykouras L (2008). Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 1308-1311.
63. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009). Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42, 270-276.
64. Scarisbrick IA, Jones EG, Isackson PJ (1993). Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. Journal of Neuroscience 13, 875-893.
65. Schmidt HD, Duman RS (2010). Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35, 2378-2391.
66. Takemura Y, Imai S, Kojima H, Katagi M, Yamakawa I, Kasahara T, Urabe H, Terashima T, Yasuda H, Chan L, Kimura H, Matsusue Y (2012). Brain-derived neurotrophic factor from bone marrow-derived cells promotes post-injury repair of peripheral nerve. PLoS ONE 7, e44592.
67. Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY (2005). Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neuroscience Letters 382, 27-32.
68. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011). Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Journal of Psychiatry and Neuroscience 36, 195-203.
69. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15, 273-289.
70. Vercammen A, Morris R, Green MJ, Lenroot R, Kulkarni J, Carr VJ, Weickert CS, Weickert TW (2012). Reduced neural activity of the prefrontal cognitive control circuitry during response inhibition to negative words in people with schizophrenia. Journal of Psychiatry and Neuroscience 37, 379-388.
71. Wagshal D, Knowlton BJ, Cohen JR, Poldrack RA, Bookheimer SY, Bilder RM, Asarnow RF (2014). Impaired automatization of a cognitive skill in first-degree relatives of patients with schizophrenia. Psychiatry Research 215, 294-299.
72. Wagshal D, Knowlton BJ, Cohen JR, Poldrack RA, Bookheimer SY, Bilder RM, Fernandez VG, Asarnow RF (2012). Deficits in probabilistic classification learning and liability for schizophrenia. Psychiatry Research 200, 167-172.
73. Wagshal D, Knowlton BJ, Suthana NA, Cohen JR, Poldrack RA, Bookheimer SY, Bilder RM, Asarnow RF (2013). Evidence for corticostriatal dysfunction during cognitive skill learning in adolescent siblings of patients with childhood-onset schizophrenia. Schizophrenia Bulletin. Published online: 25 October 2013. doi:10.1093/schbul/sbt147.
74. Wechsler D (1997). Wechsler Adult Intelligence Scale. The Psychological Corporation: San Antonio, TX.
75. Wechsler D (2001). Wechsler Test of Adult Reading. The Psychological Corporation: San Antonio, TX.
76. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 8, 592-610.
77. Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, Herman MM, Weinberger DR, Kleinman JE (2005). Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 10, 637-650.
78. Weickert TW, Goldberg TE, Callicott JH, Chen Q, Apud JA, Das S, Zoltick BJ, Egan MF, Meeter M, Myers C, Gluck MA, Weinberger DR, Mattay VS (2009). Neural correlates of probabilistic category learning in patients with schizophrenia. Journal of Neuroscience 29, 1244-1254.
79. Weickert TW, Goldberg TE, Egan MF, Apud JA, Meeter M, Myers CE, Gluck MA, Weinberger DR (2010). Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings. Biological Psychiatry 67, 948-955.
80. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR (2000). Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry 57, 907-913.
81. Weickert TW, Terrazas A, Bigelow LB, Malley JD, Hyde T, Egan MF, Weinberger DR, Goldberg TE (2002). Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learning and Memory 9, 430-442.
82. Wetmore C, Olson L, Bean AJ (1994). Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. Journal of Neuroscience 14, 1688-1700.
83. Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS (2010). Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 169, 1071-1084.
84. Wong J, Rothmond DA, Webster MJ, Weickert CS (2013). Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia. Schizophrenia Bulletin 39, 130-140.
85. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667.
86. Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen da C, Kosten TR, Zhang XY (2009). Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33, 1508-1512.
87. Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T (1996). Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochemical Research 21, 929-938.
88. Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, Yuan Y, Deng L (2008). Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. Journal of Clinical Psychiatry 69, 1104-1111.
89. Zhang XY, Chen da C, Xiu MH, Haile CN, Luo X, Xu K, Zhang HP, Zuo L, Zhang Z, Zhang X, Kosten TA, Kosten TR (2012a). Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Human Genetics 131, 1187-1195.
90. Zhang XY, Liang J, Chen da C, Xiu MH, Yang FD, Kosten TA, Kosten TR (2012b). Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology 222, 277-284.